Significance of Next-Generation Sequencing (NGS) in Prognosis and Treatment of Cancer

Abstract

Many Technical developments for genome sequencing leads results the application of next-generation sequencing to oncology have cover the route for molecular profile-based individualization of cancer patient care. Although recent research findings provide evidence that favors this method in certain forms of advanced cancer, based on uses of next-generation sequencing trials in the labs is still an unresolved topic. Clinical research is quickly changed, from Master protocols, and platform trial to clinical oncology research with adaptive design accuracy, genomic-molecular information also takes the place of biomarkers traditional objective validation processes. Nowadays, doctors need to conscious about of the available clinical results support these latest next-generation sequencing and biomarkers experiments to utilize at the point of time from a crucial point of aspect.A systematic guide for the implementation of Clinical Cancer Detection in authentic routine practice includes the status of present targeted drugs will be successful upon molecular modifications needed, now the next-generation sequence trails widely accessible.